Citi Downgrades Abbott Labs (ABT) to Sell

Citi analyst Amit Hazan downgraded Abbott Labs (NYSE: ABT) from Neutral to Sell with a price target of $68.00 (from $72.00).

For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.

Shares of Abbott Labs closed at $72.33 yesterday.

You May Also Be Interested In

• Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
• Chemtrade Logistics Income Fund (CHE-U:CN) (CGIFF) PT Raised to Cdn$18.50 at Desjardins
• Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins